David Musket
Directeur/Membre du Conseil chez CAPRICOR THERAPEUTICS, INC.
Fortune : 282 158 $ au 30/04/2024
Postes actifs de David Musket
Sociétés | Poste | Début | Fin |
---|---|---|---|
CAPRICOR THERAPEUTICS, INC. | Directeur/Membre du Conseil | 20/11/2013 | - |
Independent Dir/Board Member | 20/11/2013 | - | |
Promed Partners LP | Corporate Officer/Principal | - | - |
Capricor, Inc.
Capricor, Inc. BiotechnologyHealth Technology Part of Capricor Therapeutics, Inc., Capricor, Inc. is a company that provides cardiac stem cell therapeutics biotechnology services. The company is based in Los Angeles, CA. The company was founded by Linda Marbán. Linda Marbán has been the CEO since incorporation. Capricor was acquired by Capricor Therapeutics, Inc. on November 21, 2013. | Directeur/Membre du Conseil | 01/01/2012 | - |
Historique de carrière de David Musket
Anciens postes connus de David Musket
Sociétés | Poste | Début | Fin |
---|---|---|---|
Musket Research Associates, Inc.
Musket Research Associates, Inc. Investment Banks/BrokersFinance Musket Research Associates, Inc. operated as an investment banking firm which specializes in healthcare services. It offerEd services to the corporate and private sectors. The company was founded in 1992 and was headquartered in Cambridge, MA. | Directeur/Membre du Conseil | 01/01/1991 | 01/01/2016 |
Fondateur | 01/01/1991 | 01/01/2016 | |
President | 01/01/1991 | 01/01/2016 | |
Secrétaire Général | 01/01/1991 | 01/01/2016 | |
Treasurer | 01/01/1991 | 01/01/2016 | |
ProMed Management, Inc.
ProMed Management, Inc. Investment ManagersFinance ProMed Management, Inc. is a hedge fund manager located in New York City | Directeur en chef des Investissements | 09/11/2010 | 27/02/2013 |
Gestionnaire de Portefeuille-Actions | - | 27/02/2013 | |
President | - | 27/02/2013 | |
MZT Holdings, Inc.
MZT Holdings, Inc. Medical SpecialtiesHealth Technology MZT Holdings, Inc. principal activity is to develop, manufacture, market, distribute and licensing of cancer diagnostic technologies and products. The products are based on proprietary nuclear matrix protein technology. The company has developed minimally invasive cancer diagnostic tests for bladder and colon cancer, cervical cancer, breast cancer and prostrate cancer, using proprietary technology and expertise. It was founded in 1987 and is headquartered Foxborough, MA. | Directeur/Membre du Conseil | - | 22/01/2008 |
Matritech, Inc.
Matritech, Inc. Medical SpecialtiesHealth Technology Matritech, Inc. is a biotechnology company principally engaged in the development, manufacture, marketing, distribution and licensing of cancer diagnostic technologies, products and services | Directeur/Membre du Conseil | 22/01/2007 | 13/12/2007 |
Conor Medsystems LLC
Conor Medsystems LLC Medical SpecialtiesHealth Technology Conor Medsystems LLC develops vascular drug delivery technologies. Its products include controlled vascular drug delivery technologies and novel stent that are used in the treatment of coronary artery disease and delivery of a broad spectrum of therapeutic agents. The company was founded by John F. Shanley in 1999 and is headquartered in Menlo Park, CA. | Directeur/Membre du Conseil | 01/01/1999 | 01/01/2007 |
Goldman Sachs & Co. LLC
Goldman Sachs & Co. LLC Financial ConglomeratesFinance Goldman Sachs & Co. LLC (GS&Co.) is a securities brokerage firm headquartered in New York City. Founded in 1927, the firm is a subsidiary of The Goldman Sachs Group, Inc. (NYSE: GS). GS&Co. provides services to help hedge funds manage risk, monitor portfolios, maintain liquidity and build their businesses. They offer clients access to global equity and derivatives markets, as well as foreign exchange, commodities, European Lefts, rates and credit across the Americas, Europe and Asia. The firm proactively monitors capital markets, searching for pockets of liquidity and news that may require changes to those strategies. Integration with the Goldman Sachs network gives clients access to the firm's sectored block trades and their insights into price discovery. Their electronic trading program provides clients with tools to manage their trades from pre-trade analytics to post-trade analysis. | Corporate Officer/Principal | 01/01/1984 | - |
░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - |
Formation de David Musket
Boston College | Undergraduate Degree |
Statistiques
Internationale
Etats-Unis | 12 |
Opérationnelle
Director/Board Member | 7 |
President | 2 |
Corporate Officer/Principal | 2 |
Sectorielle
Health Technology | 7 |
Finance | 4 |
Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 1 |
---|---|
CAPRICOR THERAPEUTICS, INC. | Health Technology |
Entreprise privées | 9 |
---|---|
Matritech, Inc.
Matritech, Inc. Medical SpecialtiesHealth Technology Matritech, Inc. is a biotechnology company principally engaged in the development, manufacture, marketing, distribution and licensing of cancer diagnostic technologies, products and services | Health Technology |
ProMed Management, Inc.
ProMed Management, Inc. Investment ManagersFinance ProMed Management, Inc. is a hedge fund manager located in New York City | Finance |
Conor Medsystems LLC
Conor Medsystems LLC Medical SpecialtiesHealth Technology Conor Medsystems LLC develops vascular drug delivery technologies. Its products include controlled vascular drug delivery technologies and novel stent that are used in the treatment of coronary artery disease and delivery of a broad spectrum of therapeutic agents. The company was founded by John F. Shanley in 1999 and is headquartered in Menlo Park, CA. | Health Technology |
Musket Research Associates, Inc.
Musket Research Associates, Inc. Investment Banks/BrokersFinance Musket Research Associates, Inc. operated as an investment banking firm which specializes in healthcare services. It offerEd services to the corporate and private sectors. The company was founded in 1992 and was headquartered in Cambridge, MA. | Finance |
Capricor, Inc.
Capricor, Inc. BiotechnologyHealth Technology Part of Capricor Therapeutics, Inc., Capricor, Inc. is a company that provides cardiac stem cell therapeutics biotechnology services. The company is based in Los Angeles, CA. The company was founded by Linda Marbán. Linda Marbán has been the CEO since incorporation. Capricor was acquired by Capricor Therapeutics, Inc. on November 21, 2013. | Health Technology |
Promed Partners LP | |
Goldman Sachs & Co. LLC
Goldman Sachs & Co. LLC Financial ConglomeratesFinance Goldman Sachs & Co. LLC (GS&Co.) is a securities brokerage firm headquartered in New York City. Founded in 1927, the firm is a subsidiary of The Goldman Sachs Group, Inc. (NYSE: GS). GS&Co. provides services to help hedge funds manage risk, monitor portfolios, maintain liquidity and build their businesses. They offer clients access to global equity and derivatives markets, as well as foreign exchange, commodities, European Lefts, rates and credit across the Americas, Europe and Asia. The firm proactively monitors capital markets, searching for pockets of liquidity and news that may require changes to those strategies. Integration with the Goldman Sachs network gives clients access to the firm's sectored block trades and their insights into price discovery. Their electronic trading program provides clients with tools to manage their trades from pre-trade analytics to post-trade analysis. | Finance |
TherOx, Inc.
TherOx, Inc. Medical SpecialtiesHealth Technology TherOx, Inc. operates as a medical device company which focuses on developing and commercializing therapies to treat ischemic and oxygen deprived tissue. Its SSO2 therapy consists of TherOx DownStream system, a mobile hardware device that interfaces with the TherOx DownStream Cartridge that controls cartridge operation wherein SSO2 solution is created and mixed with the patient's blood to create superoxygenated blood for delivery to the coronary arteries. The company was founded by David B. Musket, Paul J. Zalesky and J. Richard Spears in 1994 and is headquartered in Irvine, CA. | Health Technology |
MZT Holdings, Inc.
MZT Holdings, Inc. Medical SpecialtiesHealth Technology MZT Holdings, Inc. principal activity is to develop, manufacture, market, distribute and licensing of cancer diagnostic technologies and products. The products are based on proprietary nuclear matrix protein technology. The company has developed minimally invasive cancer diagnostic tests for bladder and colon cancer, cervical cancer, breast cancer and prostrate cancer, using proprietary technology and expertise. It was founded in 1987 and is headquartered Foxborough, MA. | Health Technology |
- Bourse
- Insiders
- David Musket
- Expérience